Pregnant Patient with Severe COVID-19 Pneumonia Treated by Intensive Immune Suppression Therapy during the Omicron (B.1.1.529) Variant Outbreak: A Successfully Treated Case

Michika Hamada¹, Youichi Yanagawa^1, , Satomi Tanaka², Hiromichi Ohasaka¹, Kei Jitsuiki¹ and Kouhei Ishikawa¹

¹Department of Acute Critical Care Medicine, Shizuoka Hospital, Juntendo University

²Department of Obstetrics, Shizuoka Hospital, Juntendo University

Cite this paper

Michika Hamada, Youichi Yanagawa, Satomi Tanaka, Hiromichi Ohasaka, Kei Jitsuiki and Kouhei Ishikawa. Pregnant Patient with Severe COVID-19 Pneumonia Treated by Intensive Immune Suppression Therapy during the Omicron (B.1.1.529) Variant Outbreak: A Successfully Treated Case. American Journal of Medical Case Reports. 2022; 10(3):51-55. doi: 10.12691/AJMCR-10-3-3

Abstract

A 35-year-old pregnant woman (gestational age, 35 weeks) developed general fatigue, headache, and joint pain following the onset fever, cough, and nasal discharge after the outbreak of the Omicron variant in Japan. The patient had obesity (body mass index, 41), depression and gestational diabetes mellitus, which was treated with insulin. On the 8th day after the onset of initial flu-like symptoms, she was admitted to our hospital because polymerase chain reaction for COVID-19 became positive. Initially, her vital signs were stable without any oxygen demand. On day 11, she required oxygen therapy (4 L/min). Chest computed tomography (CT) showed multiple bilateral centrilobular patch consolidations with several subpleural lesions. As she had multiple risk factors for acute respiratory distress syndrome (ARDS), she underwent emergency cesarean section and immune modulation therapy was initiated. After the operation, her oxygenation deteriorated and she underwent tracheal intubation and mechanical ventilation on day 13. After multimodal therapy, her lung function improved and she was extubated on day 16. After rehabilitation and baby care training, she was discharged on day 27 without sequelae. This is the case of a pregnant woman with severe COVID-19 pneumonia who was successfully treated by emergency cesarean section, intensive immune suppression therapy and mechanical ventilation during the Omicron variant outbreak in Japan. The present case suggests that even pregnant women should receive COVID-19 vaccination to avoid the onset of ARDS, a potentially fatal condition.

Keywords

COVID-19, omicron variant, steroid pulse, pregnant

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Villar J, Ariff S, Gunier RB, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021; 175(8): 817-826.
[2]	Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J. Impact of Diabetes in Patients Diagnosed With COVID-19. Front Immunol. 2020 Dec 1; 11: 576818.
[3]	Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, Labrique A, Mohan D. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS One. 2021 Mar 4; 16(3): e0247461.
[4]	Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021 Dec 11; 398(10317): 2126-2128.
[5]	Long B, Carius BM, Chavez S, Liang SY, Brady WJ, Koyfman A, Gottlieb M. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation. Am J Emerg Med. 2022 Jan 21; 54: 46-57.
[6]	Zhao X, Liu B, Yu Y, Wang X, Du Y, Gu J, Wu X. The characteristics and clinical value of chest CT images of novel coronavirus pneumonia. Clin Radiol. 2020 May; 75(5): 335-340.
[7]	Lin L, Fu G, Chen S, Tao J, Qian A, Yang Y, Wang M. CT Manifestations of Coronavirus Disease (COVID-19) Pneumonia and Influenza Virus Pneumonia: A Comparative Study. AJR Am J Roentgenol. 2021 Jan; 216(1): 71-79.
[8]	Ito I, Ishida T, Togashi K, Niimi A, Koyama H, Ishimori T, Kobayashi H, Mishima M. Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography. Eur J Radiol. 2009 Dec; 72(3): 388-95.
[9]	Hanak V, Golbin JM, Ryu JH. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin Proc. 2007 Jul; 82(7): 812-6.
[10]	Majeed Z. WHO: Omicron Affects Upper Respiratory Tract, Causes Severe Pneumonia But Mild Symptoms. Republic World Last Updated: 5th January, 2022 11: 32 IST (February 14, 2022) https://www.republicworld.com/world-news/rest-of-the-world-news/who-omicron-affects-upper-respiratory-tract-causes-severe-pneumonia-but-mild-symptoms-articleshow.html.
[11]	Jitsuiki K, Katayama I, Iida T, Nagatomo S, Yanagawa Y. Successful Treatment of Elderly Male With COVID-19 Infection With Severe Acute Respiratory Distress Syndrome Using Multimodal Therapy, Including Immune Modulation Therapy.　Cureus. 2020 Dec 31; 12(12): e12402.
[12]	Muramatsu KI, Ishikawa K, Komatsu A, Jitsuiki K, Yanagawa Y. Severe COVID-19 Pneumonia Treated by Intensive Immune Suppression Therapy With a Combination of Steroid Pulse and Tocilizumab Followed by a Tapering Dose of Steroid Therapy During the Delta (B.1.617.2) Variant Outbreak: A Successfully Treated Case. Cureus. 2021 Nov 7; 13(11): e19340.
[13]	Hamada M, Jitsuiki K, Ikegami S, Ohsaka H, Yanagawa Y. Acute Respiratory Distress Syndrome Induced by COVID-19 successfully Treated by Multidisciplinary Treatment Including Steroid Pulse Therapy. Am J Med Case Rep. 2021; 9(6): 331-334.
[14]	Shuai H, Chan JF, Hu B, Chai Y, Yuen TT, Yin F, Huang X, Yoon C, Hu JC, Liu H, Shi J, Liu Y, Zhu T, Zhang J, Hou Y, Wang Y, Lu L, Cai JP, Zhang AJ, Zhou J, Yuan S, Brindley MA, Zhang BZ, Huang JD, To KK, Yuen KY, Chu H. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature. 2022 Jan 21.
[15]	Modes ME, Directo MP, Melgar M, Johnson LR, Yang H, Chaudhary P, Bartolini S, Kho N, Noble PW, Isonaka S, Chen P. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 11; 71(6): 217-223.
[16]	Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, Amoako DG, Everatt J, Bhiman JN, Scheepers C, Tebeila N, Chiwandire N, du Plessis M, Govender N, Ismail A, Glass A, Mlisana K, Stevens W, Treurnicht FK, Makatini Z, Hsiao NY, Parboosing R, Wadula J, Hussey H, Davies MA, Boulle A, von Gottberg A, Cohen C. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 Jan 29; 399(10323): 437-446.
[17]	Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, Marquez PL, Olson CK, Liu R, Chang KT, Ellington SR, Burkel VK, Smoots AN, Green CJ, Licata C, Zhang BC, Alimchandani M, Mba-Jonas A, Martin SW, Gee JM, Meaney-Delman DM; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021 Jun 17; 384(24): 2273-2282.
[18]	Burki TK. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2022 Feb; 10(2): e17.